{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:11Z","timestamp":1753891571639,"version":"3.41.2"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neuroinform."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Several observational studies have explored the relationships between multiple sclerosis (MS) and breast cancer; however, whether an association exists remains unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a meta-analysis of observational studies and Mendelian randomization (MR) based on genetic variants to identify the relationship between MS and breast cancer. The observational studies were searched from PubMed, Embase, Web of Science, and Scopus to assess the relationship between MS and breast cancer from inception to 07 Nov 2022. Moreover, we explored the association between genetically pre-disposed MS and breast cancer risk based on an MR study. The summary analysis for MS from two separate databases [International Multiple Sclerosis Genetics Consortium (IMSGC), FinnGen] and the summary analysis for breast cancer from Breast Cancer Association Consortium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifteen cohort studies involving 173,565 female MS patients were included in this meta-analysis. The correlation between MS and breast cancer was not statistically significant [relative ratio (RR) = 1.08, 95% confidence interval (CI) = 0.99\u20131.17]. In the MR analysis, we did not observe causal associations of genetically determined MS with breast cancer and its subtypes from both the IMSGC and FinnGen datasets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The meta-analysis of observational and MR based on genetic variants does not support the correlation between MS and breast cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fninf.2023.1154916","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:36:40Z","timestamp":1683088600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Multiple sclerosis and breast cancer risk: a meta-analysis of observational and Mendelian randomization studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Tian","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10549-004-2229-4","article-title":"Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.","volume":"89","author":"Achiron","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/aje\/kwj252","article-title":"Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry.","volume":"164","author":"Alder","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000959","article-title":"Clinical and radiologic disease activity in pregnancy and postpartum in MS.","volume":"8","author":"Anderson","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","article-title":"Cancer risk among patients with multiple sclerosis and their parents.","volume":"72","author":"Bahmanyar","year":"2009","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/ene.15226","article-title":"Incidence and risk of cancer among multiple sclerosis patients: A matched population-based cohort study.","volume":"29","author":"Bosco-L\u00e9vy","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: A review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res. Synth. Methods"},{"key":"B7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR\u2212Egger regression: The role of the I2 statistic.","volume":"45","author":"Bowden","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat. Methods Med. Res."},{"key":"B11","first-page":"513","article-title":"[Incidence of breast cancer in women with multiple sclerosis: Systematic review and meta-analysis of observational cohort studies].","volume":"51","author":"Catal\u00e1-L\u00f3pez","year":"2010","journal-title":"Rev. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archdermatol.2011.212","article-title":"Melanoma occurring during treatment with fingolimod for multiple sclerosis: A case report.","volume":"147","author":"Conzett","year":"2011","journal-title":"Arch. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: Genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomization studies: A guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited.","author":"DerSimonian","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s13311-021-01073-y","article-title":"Association between disease-modifying therapies prescribed to persons with multiple sclerosis and cancer: A WHO pharmacovigilance database analysis.","volume":"18","author":"Dolladille","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"B18","first-page":"172","article-title":"Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran.","volume":"8","author":"Etemadifar","year":"2017","journal-title":"Caspian J. Intern. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin Exp. Immunol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10100758","article-title":"Anti-CD20 agents for multiple sclerosis: Spotlight on ocrelizumab and ofatumumab.","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1212\/WNL.0000000000200163","article-title":"Multiple sclerosis and the cancer diagnosis: Diagnostic route, cancer stage, and the diagnostic interval in breast and colorectal cancer.","volume":"98","author":"Groome","year":"2022","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1177\/1352458519877244","article-title":"Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.","volume":"26","author":"Grytten","year":"2020","journal-title":"Mult. Scler."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165027","article-title":"Risk of premenopausal and postmenopausal breast cancer among multiple sclerosis patients.","volume":"11","author":"Hajiebrahimi","year":"2016","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies.","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers.","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj."},{"key":"B27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/WNL.0b013e3181c777b7","article-title":"Cancer risk among patients with multiple sclerosis and their parents.","volume":"74","author":"Hofer","year":"2010","journal-title":"Neurology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejmg.2013.07.006","article-title":"Co-occurrence of multiple sclerosis and cancer in a BRCA1 positive family.","volume":"56","author":"Holzmann","year":"2013","journal-title":"Eur. J. Med. Genet."},{"key":"B29","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.","volume":"365","year":"2019","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243150","article-title":"Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.","volume":"16","author":"Johnson","year":"2021","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/11795735211037785","article-title":"Breast carcinoma after ocrelizumab therapy in multiple sclerosis patients: A case series and literature review.","volume":"13","author":"Kelsey","year":"2021","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1093\/brain\/aws148","article-title":"Cancer risk in multiple sclerosis: Findings from British Columbia, Canada.","author":"Kingwell","year":"2012","journal-title":"Brain."},{"key":"B33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: A meta-analysis.","volume":"121","author":"Larsson","year":"2007","journal-title":"Int. J. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/1352458507083625","article-title":"Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.","volume":"14","author":"Lebrun","year":"2008","journal-title":"Mult. Scler."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103679","article-title":"Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents.","volume":"60","author":"Mariottini","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1212\/WNL.0000000000011219","article-title":"Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study.","volume":"96","author":"Marrie","year":"2021","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02954","article-title":"Multiple sclerosis and cancer: The ying-yang effect of disease modifying therapies.","volume":"10","author":"Melamed","year":"2019","journal-title":"Front. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","article-title":"Association analysis identifies 65 new breast cancer risk loci.","volume":"551","author":"Michailidou","year":"2017","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1600-0404.1996.tb00019.x","article-title":"Multiple sclerosis and cancer in Norway. A retrospective cohort study.","volume":"93","author":"Midgard","year":"1996","journal-title":"Acta Neurol. Scand."},{"key":"B40","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ijc.21437","article-title":"Cancer risk among patients with multiple sclerosis: A population-based register study.","volume":"118","author":"Nielsen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.msard.2018.12.014","article-title":"Multiple sclerosis and cancer incidence: A Danish nationwide cohort study.","volume":"28","author":"N\u00f8rgaard","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jns.2015.06.033","article-title":"Multiple sclerosis and breast cancer.","volume":"356","author":"O\u2019Malley","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2741\/4230","article-title":"The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.","volume":"19","author":"Paul","year":"2014","journal-title":"Front. Biosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103233","article-title":"Emerging role of follicular T Helper cells in multiple sclerosis and experimental autoimmune encephalomyelitis.","volume":"19","author":"Quinn","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0932-0","article-title":"Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: A cohort study.","volume":"17","author":"Ragonese","year":"2017","journal-title":"BMC Neurol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: Concepts and scope.","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/humupd\/dms051","article-title":"Controlled ovarian hyperstimulation for IVF: Impact on ovarian, endometrial and cervical cancer\u2013a systematic review and meta-analysis.","volume":"19","author":"Siristatidis","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"B49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/B978-0-12-819410-2.00024-2","article-title":"Multiple sclerosis: Inflammation, autoimmunity and plasticity.","volume":"184","author":"Stampanoni Bassi","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/eji.200839073","article-title":"Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg.","volume":"39","author":"Stephens","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000079947","article-title":"Cancer incidence in multiple sclerosis: A 35-year follow-up.","volume":"23","author":"Sumelahti","year":"2004","journal-title":"Neuroepidemiology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ene.12267","article-title":"Increased breast cancer risk for patients with multiple sclerosis: A nationwide population-based cohort study.","volume":"21","author":"Sun","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EDE.0000000000000081","article-title":"Methodological challenges in Mendelian randomization.","volume":"25","author":"VanderWeele","year":"2014","journal-title":"Epidemiology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00415-020-10170-5","article-title":"Increasing cancer risk over calendar year in people with multiple sclerosis: A case-control study.","volume":"268","author":"Zecca","year":"2021","journal-title":"J. Neurol."}],"container-title":["Frontiers in Neuroinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fninf.2023.1154916\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:36:44Z","timestamp":1683088604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fninf.2023.1154916\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":56,"alternative-id":["10.3389\/fninf.2023.1154916"],"URL":"https:\/\/doi.org\/10.3389\/fninf.2023.1154916","relation":{},"ISSN":["1662-5196"],"issn-type":[{"type":"electronic","value":"1662-5196"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"article-number":"1154916"}}